Your browser doesn't support javascript.
loading
Prognostic factors and effect on survival of immune-related adverse events in patients with non-small-cell lung cancer treated with immune checkpoint blockage.
Conde-Estévez, David; Monge-Escartín, Inés; Ríos-Hoyo, Alejandro; Monzonis, Xavier; Echeverría-Esnal, Daniel; Moliner, Laura; Duran-Jordà, Xavier; Taus, Álvaro; Arriola, Edurne.
Afiliação
  • Conde-Estévez D; Department of Pharmacy, Hospital Universitari del Mar, Barcelona, Spain.
  • Monge-Escartín I; IMIM (Instituto de Investigación Hospital del Mar), Barcelona, Spain.
  • Ríos-Hoyo A; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autónoma de Barcelona, Barcelona, Spain.
  • Monzonis X; Department of Pharmacy, Hospital Universitari del Mar, Barcelona, Spain.
  • Echeverría-Esnal D; Department of Medical Oncology, Hospital Universitari del Mar-CIBERONC, Barcelona, Spain.
  • Moliner L; Department of Medical Oncology, Hospital Universitari del Mar-CIBERONC, Barcelona, Spain.
  • Duran-Jordà X; Department of Pharmacy, Hospital Universitari del Mar, Barcelona, Spain.
  • Taus Á; Department of Medical Oncology, Hospital Universitari del Mar-CIBERONC, Barcelona, Spain.
  • Arriola E; IMIM (Instituto de Investigación Hospital del Mar), Barcelona, Spain.
J Chemother ; 33(1): 32-39, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33267748
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antineoplásicos Imunológicos / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antineoplásicos Imunológicos / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Idioma: En Ano de publicação: 2021 Tipo de documento: Article